Last updated: June 7, 2024
Sponsor: First Affiliated Hospital of Fujian Medical University
Overall Status: Active - Recruiting
Phase
1
Condition
Carcinoma
Cancer
Treatment
68Ga-JH04
68Ga-FAPI/18F-FDG
Clinical Study ID
NCT06455735
FirstAHFujian-68Ga-JH04 PET/CT
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Various solid tumors with available histopathological findings Signed informed consent
Exclusion
Exclusion Criteria:
pregnant or lactational women who suffered from severe hepatic and renal insufficiency
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: 68Ga-JH04
Phase: 1
Study Start date:
March 01, 2024
Estimated Completion Date:
April 01, 2026
Study Description
Connect with a study center
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian 350000
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.